EXHIBIT
32
CERTIFICATION
PURSUANT TO 18 U.S.C.
SECTION
1350 AS ADOPTED PURSUANT TO SECTION 906
OF
THE
SARBANES-OXLEY ACT OF 2002
This
certification set forth below is hereby made solely for the purposes of
satisfying the requirements of Section 906 of the Sarbanes-Oxley Act of
2002 and may not be relied upon or used for any other purposes.
A
signed
original of this written statement required by Section 906 has been provided
to
Access Pharmaceuticals, Inc. and will be retained by Access Pharmaceuticals,
Inc. and furnished to the SEC or its staff upon its request.
Pursuant
to Section 906 of the Public Company Accounting Reform and Investor Act of
2002
(18 U.S.C. 1350, as adopted, the “Sarbanes-Oxley Act”), Stephen R. Seiler,
President and Chief Executive Officer of Access Pharmaceuticals, Inc. (the
"Company"), and Stephen B. Thompson, Vice President and Chief Financial Officer
of the Company, each hereby certifies that to his knowledge the Annual Report
on
Form 10-KSB for the period ended December 31, 2006 of the Company filed with
the
Securities and Exchange Commission on the date hereof (the "Report") fully
complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and the information contained in the Report fairly
presents, in all material respects, the financial condition and results of
operations of the Company for the period specified.
Signed
at
the City of Dallas, in the State of Texas, this 2nd day of April,
2007.
/s/ Stephen
R. Seiler |
|
/s/ Stephen
B. Thompson |
|
Stephen R. Seiler |
Stephen B. Thompson |
President and Chief Executive Officer |
Chief Financial
Officer |